Dengue fever in a multiple sclerosis patient taking ocrelizumab: Clinical commentary

Mult Scler. 2021 Nov;27(13):2118-2119. doi: 10.1177/13524585211039750. Epub 2021 Aug 27.

Authors

Ricardo Alonso¹, Lorna Galleguillos²

Affiliations

¹ Neurology, Multiple Sclerosis University Center, Hospital Ramos Mejίa, Buenos Aires, Argentina.
² Neuroimmunology, Neurologίa y Psiquiatria, Clinica Alemana de Santiago SA, Santiago, Chile Clinica Davila, Neurologίa y Neurocirugίa, Santiago, Chile.

PMID: 34449279
DOI: 10.1177/13524585211039750

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Dengue* / drug therapy
Humans
Multiple Sclerosis* / drug therapy
Multiple Sclerosis, Chronic Progressive*

Substances

Antibodies, Monoclonal, Humanized
ocrelizumab